[
  {
    "title": "Revvity Signals Software\u2019s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners",
    "published": 1713175200,
    "posting_price": 104.08864276,
    "close_price": 102.06372833,
    "percent_change": -1.945375
  },
  {
    "title": "Revvity Inc. stock underperforms Friday when compared to competitors",
    "published": 1712895660,
    "posting_price": 107.19085477,
    "close_price": 103.23079681,
    "percent_change": -3.69439909
  },
  {
    "title": "Revvity (RVTY) Stock Jumps 4.1%: Will It Continue to Soar?",
    "published": 1712757780,
    "posting_price": 107.74945533,
    "close_price": 107.62976074,
    "percent_change": -0.11108603
  },
  {
    "title": "Barclays Keeps Their Hold Rating on Revvity (RVTY)",
    "published": 1712713740,
    "posting_price": 107.74945533,
    "close_price": 107.62976074,
    "percent_change": -0.11108603
  },
  {
    "title": "Revvity (RVTY) Shares Cross Above 200 DMA",
    "published": 1712656740,
    "posting_price": 107.72950682,
    "close_price": 110.44269562,
    "percent_change": 2.51851965
  },
  {
    "title": "Revvity Now #441 Largest Company, Surpassing J.M. Smucker",
    "published": 1712549340,
    "posting_price": 102.07371042,
    "close_price": 106.14349365,
    "percent_change": 3.98710227
  },
  {
    "title": "Revvity, Inc. (NYSE:RVTY) is largely controlled by institutional shareholders who own 80% of the company",
    "published": 1712413972,
    "posting_price": 102.07371042,
    "close_price": 106.14349365,
    "percent_change": 3.98710227
  },
  {
    "title": "Revvity To Hold Earnings Call on Monday, April 29, 2024",
    "published": 1712232000,
    "posting_price": 103.04127638,
    "close_price": 101.42533112,
    "percent_change": -1.56825043
  },
  {
    "title": "Preliminary Injunction Granted to Enforce Revvity s Rights and Cloud Software Group s Obligations Related to Spotfire Software",
    "published": 1712141380,
    "posting_price": 101.74453656,
    "close_price": 102.09365845,
    "percent_change": 0.34313576
  },
  {
    "title": "Revvity Inc. stock outperforms competitors on strong trading day",
    "published": 1712118120,
    "posting_price": 101.74453656,
    "close_price": 102.09365845,
    "percent_change": 0.34313576
  },
  {
    "title": "Preliminary Injunction Granted to Enforce Revvity\u2019s Rights and Cloud Software Group\u2019s Obligations Related to Spotfire Software",
    "published": 1712052000,
    "posting_price": 102.06373512,
    "close_price": 101.95401001,
    "percent_change": -0.10750646
  },
  {
    "title": "Revvity announces preliminary injunction compelling CSG to comply with contract",
    "published": 1712034180,
    "posting_price": 102.06373512,
    "close_price": 101.95401001,
    "percent_change": -0.10750646
  },
  {
    "title": "4 Analysts Have This To Say About Revvity",
    "published": 1714475280,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity : Q1 2024 Earnings Transcript",
    "published": 1714471454,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity Inc (RVTY) Q1 2024 Earnings Call Transcript Highlights: Surpassing Expectations with ...",
    "published": 1714460486,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity price target raised by $7 at TD Cowen, here's why",
    "published": 1714458120,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Stifel Nicolaus Remains a Hold on Revvity (RVTY)",
    "published": 1714458060,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), DocGo (DCGO) and Revvity (RVTY)",
    "published": 1714458060,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity price target raised by $1 at Baird, here's why",
    "published": 1714455360,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity (RVTY) Receives a Hold from Barclays",
    "published": 1714452360,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Q1 2024 Revvity Inc Earnings Call",
    "published": 1714444603,
    "posting_price": 104.111259,
    "close_price": 102.28456879,
    "percent_change": -1.75455587
  },
  {
    "title": "Revvity Inc (RVTY) Q1 Earnings: Adjusted EPS Beats Estimates, Revenue Declines",
    "published": 1714399894,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity (RVTY) Reports Q1 Earnings: What Key Metrics Have to Say",
    "published": 1714397406,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity beats quarterly estimates on demand for diagnostic equipment",
    "published": 1714390780,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity, Inc. (RVTY) Q1 2024 Earnings Call Transcript",
    "published": 1714390090,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity (RVTY) Beats Q1 Earnings and Revenue Estimates",
    "published": 1714389003,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity Announces Financial Results for the First Quarter of 2024",
    "published": 1714384800,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "RVTY Stock Earnings: Revvity Beats EPS, Beats Revenue for Q1 2024",
    "published": 1714384500,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity: Q1 Earnings Snapshot",
    "published": 1714370948,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity beats top-line and bottom-line estimates; updates FY24 outlook",
    "published": 1714367340,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity still sees 2024 non-GAAP EPS $4.55-$4.75, consensus",
    "published": 1714367040,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity reports Q1 adjusted EPS 98c, consensus 93c",
    "published": 1714366920,
    "posting_price": 103.24282941,
    "close_price": 104.82994843,
    "percent_change": 1.53726804
  },
  {
    "title": "Revvity Board Declares Quarterly Dividend",
    "published": 1714076100,
    "posting_price": 102.21470239,
    "close_price": 101.90525818,
    "percent_change": -0.30273943
  },
  {
    "title": "Revvity to Present at BofA Securities 2024 Health Care Conference",
    "published": 1714046400,
    "posting_price": 102.21470239,
    "close_price": 101.90525818,
    "percent_change": -0.30273943
  },
  {
    "title": "Revvity\u2019s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings",
    "published": 1714037416,
    "posting_price": 102.21470239,
    "close_price": 101.90525818,
    "percent_change": -0.30273943
  },
  {
    "title": "Revvity declares $0.07 dividend",
    "published": 1714017060,
    "posting_price": 102.21470239,
    "close_price": 101.90525818,
    "percent_change": -0.30273943
  },
  {
    "title": "Revvity Unveils a New Era of Automated Tuberculosis Testing",
    "published": 1713952800,
    "posting_price": 102.49417877,
    "close_price": 102.49417877,
    "percent_change": 0.0
  },
  {
    "title": "Investors in Revvity (NYSE:RVTY) have unfortunately lost 25% over the last three years",
    "published": 1713814990,
    "posting_price": 100.81723363,
    "close_price": 100.58764648,
    "percent_change": -0.2277261
  },
  {
    "title": "Revvity Signals Software's New Synergy Solution Redefines Collaboration between Pharma and Contract Partners",
    "published": 1713253219,
    "posting_price": 101.77446385,
    "close_price": 100.02884674,
    "percent_change": -1.71518183
  }
]